72 related articles for article (PubMed ID: 7594593)
21. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.
Zweerink HJ; Gammon MC; Utz U; Sauma SY; Harrer T; Hawkins JC; Johnson RP; Sirotina A; Hermes JD; Walker BD
J Immunol; 1993 Mar; 150(5):1763-71. PubMed ID: 7679694
[TBL] [Abstract][Full Text] [Related]
22. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes.
Ramachandra L; Song R; Harding CV
J Immunol; 1999 Mar; 162(6):3263-72. PubMed ID: 10092778
[TBL] [Abstract][Full Text] [Related]
23. Immunoregulation of Th cells by naturally processed peptide antagonists.
Carson RT; Desai DD; Vignali KM; Vignali DA
J Immunol; 1999 Jan; 162(1):1-4. PubMed ID: 9886362
[TBL] [Abstract][Full Text] [Related]
24. Immunodominance does not result from peptide competition for MHC class II presentation.
Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
[TBL] [Abstract][Full Text] [Related]
25. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
26. MHC/peptide binding studies indicate hierarchy of anchor residues.
Deres K; Beck W; Faath S; Jung G; Rammensee HG
Cell Immunol; 1993 Oct; 151(1):158-67. PubMed ID: 8402926
[TBL] [Abstract][Full Text] [Related]
27. Diversity in MHC class II ovalbumin T cell epitopes generated by distinct proteases.
Vidard L; Rock KL; Benacerraf B
J Immunol; 1992 Jul; 149(2):498-504. PubMed ID: 1378066
[TBL] [Abstract][Full Text] [Related]
28. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
Dillon SR; Jameson SC; Fink PJ
J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
[TBL] [Abstract][Full Text] [Related]
29. The MHC class I-restricted immune response to HIV-gag in BALB/c mice selects a single epitope that does not have a predictable MHC-binding motif and binds to Kd through interactions between a glutamine at P3 and pocket D.
Mata M; Travers PJ; Liu Q; Frankel FR; Paterson Y
J Immunol; 1998 Sep; 161(6):2985-93. PubMed ID: 9743362
[TBL] [Abstract][Full Text] [Related]
30. Sequences that flank subdominant and cryptic epitopes influence the proteolytic generation of MHC class I-presented peptides.
Mo AX; van Lelyveld SF; Craiu A; Rock KL
J Immunol; 2000 Apr; 164(8):4003-10. PubMed ID: 10754291
[TBL] [Abstract][Full Text] [Related]
31. Functional mapping of the orientation for TCR recognition of an H2-Kb-restricted ovalbumin peptide suggests that the beta-chain subunit can dominate the determination of peptide side chain specificity.
Turner SJ; Jameson SC; Carbone FR
J Immunol; 1997 Sep; 159(5):2312-7. PubMed ID: 9278320
[TBL] [Abstract][Full Text] [Related]
32. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
[TBL] [Abstract][Full Text] [Related]
33. Presentation without proteolytic cleavage of endogenous precursors in the MHC class I antigen processing pathway.
Buchholz D; Scott P; Shastri N
J Biol Chem; 1995 Mar; 270(12):6515-22. PubMed ID: 7896786
[TBL] [Abstract][Full Text] [Related]
34. Tripeptidyl peptidase II is the major peptidase needed to trim long antigenic precursors, but is not required for most MHC class I antigen presentation.
York IA; Bhutani N; Zendzian S; Goldberg AL; Rock KL
J Immunol; 2006 Aug; 177(3):1434-43. PubMed ID: 16849449
[TBL] [Abstract][Full Text] [Related]
35. Molecular signals for phosphatidylinositol modification of the Qa-2 antigen.
Ulker N; Hood LE; Stroynowski I
J Immunol; 1990 Oct; 145(7):2214-9. PubMed ID: 2398278
[TBL] [Abstract][Full Text] [Related]
36. Characterizing the specificity and cooperation of aminopeptidases in the cytosol and endoplasmic reticulum during MHC class I antigen presentation.
Hearn A; York IA; Bishop C; Rock KL
J Immunol; 2010 May; 184(9):4725-32. PubMed ID: 20351195
[TBL] [Abstract][Full Text] [Related]
37. Importance of the COOH terminal of angiotensin in antigenicity and in the formation of an antigen-containing complex with cellular membrane structures.
Thomas DW; Solvay MJ; Irani DN; Nairn R
J Immunol; 1985 Dec; 135(6):4086-9. PubMed ID: 4067310
[TBL] [Abstract][Full Text] [Related]
38. Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism.
Malarkannan S; Horng T; Shih PP; Schwab S; Shastri N
Immunity; 1999 Jun; 10(6):681-90. PubMed ID: 10403643
[TBL] [Abstract][Full Text] [Related]
39. Immunoglobulin as a vehicle for foreign antigenic peptides immunogenic to T cells.
Lunde E; Bogen B; Sandlie I
Mol Immunol; 1997; 34(16-17):1167-76. PubMed ID: 9566764
[TBL] [Abstract][Full Text] [Related]
40. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein.
Del Val M; Schlicht HJ; Ruppert T; Reddehase MJ; Koszinowski UH
Cell; 1991 Sep; 66(6):1145-53. PubMed ID: 1913805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
